Tin tức & Cập nhật
Xem bài viết Nhi khoa
Xem
Infliximab, vedolizumab similarly effective as 1L Tx for paediatric IBD
In a study presented at Crohn’s and Colitis Congress 2024, infliximab and vedolizumab were found to have similar effectiveness in achieving steroid-free clinical remission (SFCR) and biochemical remission (BR) at 12 months when used as first-line treatment for biologic-naïve paediatric patients with uncomplicated mild-to-moderately active inflammatory bowel disease (IBD).
Infliximab, vedolizumab similarly effective as 1L Tx for paediatric IBD
22 Feb 2024
Cardiogenic shock ups risk of death in hospitalized children with ADHF
Nearly one in four children hospitalized for acute decompensated heart failure (ADHF) had cardiogenic shock (CS), which may lead to death, reports a study.
Cardiogenic shock ups risk of death in hospitalized children with ADHF
11 Feb 2024
Cardiovascular risks high after PCI, CABG but decrease in time
Early revascularization by percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), compared with a conservative (CON) strategy, may result in higher early risks but lower long-term risks of cardiovascular events in patients with stable coronary artery disease treated with an invasive (INV) strategy, a study has found.
